Meta Pixel

News and Announcements

Turning Investor Rejection into Opportunity: How to Leverage a “No” for Future Success

  • Published June 18, 2023 11:00PM UTC
  • Publisher Steve Torso
  • Categories Capital Raising Tips

Receiving a rejection from an investor can feel disheartening, but what if I told you it could actually be a valuable asset? In this enlightening video, we delve into the art of transforming investor rejection into a powerful advantage for your future fundraising endeavors.

YouTube player

Getting a “no” from an investor is not only common but also inevitable. Rather than letting it discourage you, learn how to leverage that rejection to your advantage. We share proven strategies and insights that will enable you to harness the power of a “no” and turn it into a stepping stone towards success.

Join us as we guide you through the process of reframing rejection and utilising it as a valuable resource in your future investor discussions. Discover how to extract valuable feedback, refine your pitch, and approach future investors with renewed confidence.

Don’t let investor rejection hold you back. Embrace the opportunity it presents and gain a competitive edge in your fundraising journey. Watch this video now and learn how to transform a “no” into a powerful asset for future investor engagements.

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now